SG Americas Securities
NUVB icon

SG Americas Securities’s Nuvation Bio NUVB Stock Holding History

SG Americas Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Sell
59,428
-27,959
-32% -$137K ﹤0.01% 2526
2026
Q1 		$375K Buy
87,387
+25,596
+41% +$143K ﹤0.01% 2336
2025
Q4 		$554K Buy
61,791
+5,395
+10% +$33.4K ﹤0.01% 2431
2025
Q3 		$209K Buy
56,396
+43,728
+345% +$119K ﹤0.01% 2726
2025
Q2 		$25K Sell
12,668
-51,592
-80% -$107K ﹤0.01% 2822
2025
Q1 		$113K Sell
64,260
-11,595
-15% -$26.4K ﹤0.01% 2956
2024
Q4 		$202K Buy
75,855
+3,798
+5% +$9.78K ﹤0.01% 2144
2024
Q3 		$165K Buy
72,057
+40,141
+126% +$122K ﹤0.01% 2642
2024
Q2 		$93K Sell
31,916
-18,710
-37% -$57.1K ﹤0.01% 2567
2024
Q1 		$184K Sell
50,626
-28,978
-36% -$55.6K ﹤0.01% 2037
2023
Q4 		$120K Sell
79,604
-30,622
-28% -$39.4K ﹤0.01% 2613
2023
Q3 		$148K Buy
110,226
+99,434
+921% +$165K ﹤0.01% 2509
2023
Q2 		$19K Sell
10,792
-14,522
-57% -$24.7K ﹤0.01% 2178
2023
Q1 		$42K Buy
25,314
+4,848
+24% +$9.83K ﹤0.01% 3087
2022
Q4 		$39K Sell
20,466
-202,565
-91% -$410K ﹤0.01% 2879
2022
Q3 		$500K Buy
223,031
+63,351
+40% +$181K 0.01% 1553
2022
Q2 		$517K Sell
159,680
-236,758
-60% -$1.03M 0.01% 1930
2022
Q1 		$2.08M Sell
396,438
-142,414
-26% -$800K 0.02% 894
2021
Q4 		$4.58M Buy
538,852
+509,929
+1,763% +$4.69M 0.02% 542
2021
Q3 		$287K Buy
+28,923
New +$262K ﹤0.01% 2981

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SG Americas Securities's NUVB Position: Q2 2026 in Review

SG Americas Securities reduced its Nuvation Bio (NUVB) stake by 32% in Q2 2026, selling an estimated $137K and leaving 59,428 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

SG Americas Securities first reported a position in NUVB in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.58M in Q4 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • SG Americas Securities held 59,428 shares of Nuvation Bio worth $338K as of Q2 2026.
  • SG Americas Securities sold 27,959 Nuvation Bio shares in Q2 2026, an estimated $137K.
  • Nuvation Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2526 holding.
  • SG Americas Securities first reported a position in Nuvation Bio in Q3 2021 and has held it in 20 quarters since.
  • SG Americas Securities's Nuvation Bio position peaked at $4.58M in Q4 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.